Related references
Note: Only part of the references are listed.Overcoming 5-Fu Resistance of Colon Cells through Inhibition of Glut1 by the Specific Inhibitor WZB117
Wei Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
HIF-1α and GLUT1 Gene Expression is Associated with Chemoresistance of Acute Myeloid Leukemia
Kui Song et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response
Ying Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin
Sarah Spreckelmeyer et al.
MOLECULES (2014)
The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients
Xiang-Ping Li et al.
TUMOR BIOLOGY (2014)
Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility
Peng Zhao et al.
BMC CANCER (2013)
Polymorphic Transporters and Platinum Pharmacodynamics
Jason A. Sprowl et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1-related Hepatocellular Carcinoma
Xi-Dai Long et al.
EPIDEMIOLOGY (2013)
Early-onset absence epilepsy: SLC2A1 gene analysis and treatment evolution
S. Agostinelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Lack of SLC2A1 (Glucose Transporter 1) Mutations in 30 Italian Patients With Alternating Hemiplegia of Childhood
Elisa De Grandis et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific
Bing Du et al.
JOURNAL OF DIABETES (2013)
Association Between XRCC5, 6 and 7 Gene Polymorphisms and the Risk of Breast Cancer: A HuGE Review and Meta-analysis
Li-Ping Zhou et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
The role of renal water channels in health and disease
Ross P. Holmes
MOLECULAR ASPECTS OF MEDICINE (2012)
Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy
Saul A. Mullen et al.
ARCHIVES OF NEUROLOGY (2011)
Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma
Thomas Amann et al.
MOLECULAR MEMBRANE BIOLOGY (2011)
A 10 bp Deletion Polymorphism and 2 New Variations in the GLUT1 Gene Associated With Meningomyelocele
Clint M. Cormier et al.
REPRODUCTIVE SCIENCES (2011)
Early-Onset Absence Epilepsy Caused by Mutations in the Glucose Transporter GLUT1
Arvid Suls et al.
ANNALS OF NEUROLOGY (2009)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population
Zhonghua Wang et al.
LUNG CANCER (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer
Daniela F. Giachino et al.
CLINICAL CANCER RESEARCH (2007)
Pharmacogenetics for individualized cancer chemotherapy
T Efferth et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria
BK Kishore et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
